{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T22:08:17Z","timestamp":1782252497513,"version":"3.54.5"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.critrevonc.2019.04.023","type":"journal-article","created":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T20:39:51Z","timestamp":1556829591000},"page":"67-74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Whole-body hyperthermia in combination with systemic therapy in advanced solid malignancies"],"prefix":"10.1016","volume":"139","author":[{"given":"G.","family":"Lassche","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Crezee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.M.L.","family":"Van Herpen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2019.04.023_bib0005","first-page":"145","article-title":"Magnetic fluid hyperthermia enhances cytotoxicity of bortezomib in sensitive and resistant cancer cell lines","volume":"9","author":"Alvarez-Berrios","year":"2014","journal-title":"Int. J. Nanomedicine"},{"issue":"2","key":"10.1016\/j.critrevonc.2019.04.023_bib0010","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.ygyno.2008.11.001","article-title":"Whole-body hyperthermia (WBH) in combination with carboplatin in patients with recurrent ovarian cancer - a phase II study","volume":"112","author":"Atmaca","year":"2009","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2019.04.023_bib0015","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0169-5002(02)00536-6","article-title":"Ifosfamide, carboplatin and etoposide combined with 41.8degreeC whole body hyperthermia for malignant pleural mesothelioma","volume":"39","author":"Bakhshandeh","year":"2003","journal-title":"Lung Cancer"},{"issue":"8","key":"10.1016\/j.critrevonc.2019.04.023_bib0020","first-page":"3069","article-title":"Preclinical and clinical aspects of carboplatin and gemcitabine combined with whole-body hyperthermia for pancreatic adenocarcinoma","volume":"29","author":"Bakshandeh-Bath","year":"2009","journal-title":"Anticancer Res."},{"issue":"4","key":"10.1016\/j.critrevonc.2019.04.023_bib0025","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1080\/02656730701378684","article-title":"Hyperthermia, cisplatin and radiation trimodality treatment: a promising cancer treatment? A review from preclinical studies to clinical application","volume":"23","author":"Bergs","year":"2007","journal-title":"Int. J. Hyperthermia"},{"issue":"6","key":"10.1016\/j.critrevonc.2019.04.023_bib0030","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1055\/s-2001-19286","article-title":"Pilot study of whole-body hyperthermia combined with chemotherapy in patients with metastasised pretreated progressive breast, ovarian, and colorectal carcinomas","volume":"22","author":"Bremer","year":"2001","journal-title":"TumorDiagnostik & Therapie"},{"issue":"3","key":"10.1016\/j.critrevonc.2019.04.023_bib0035","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3109\/02656739209021784","article-title":"Chemotherapy resistant sarcoma treated with whole body hyperthermia (WBH) combined with 1-3-bis(2-chloroethyl)-1-nitrosourea (BCNU)","volume":"8","author":"Bull","year":"1992","journal-title":"Int. J. Hyperthermia."},{"issue":"8","key":"10.1016\/j.critrevonc.2019.04.023_bib0040","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1080\/02656730802104740","article-title":"Fever-range whole-body thermal therapy combined with cisplatin, gemcitabine, and daily interferon-alpha: a description of a phase I-II protocol","volume":"24","author":"Bull","year":"2008","journal-title":"Int. J. Hyperthermia."},{"issue":"6","key":"10.1016\/j.critrevonc.2019.04.023_bib0045","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/j.1464-410X.2010.09654.x","article-title":"Long-term outcomes of a randomized controlled trial comparing thermochemotherapy with mitomycin-C alone as adjuvant treatment for non-muscle-invasive bladder cancer (NMIBC)","volume":"107","author":"Colombo","year":"2011","journal-title":"BJU Int."},{"issue":"5","key":"10.1016\/j.critrevonc.2019.04.023_bib0050","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.ijrobp.2015.12.361","article-title":"Hyperthermia and radiation therapy in Locoregional recurrent breast cancers: a systematic review and meta-analysis","volume":"94","author":"Datta","year":"2016","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.critrevonc.2019.04.023_bib0055","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3109\/02656736.2015.1099746","article-title":"Hyperthermia and radiotherapy in the management of head and neck cancers: a systematic review and meta-analysis","volume":"32","author":"Datta","year":"2016","journal-title":"Int. J. Hyperthermia."},{"issue":"4","key":"10.1016\/j.critrevonc.2019.04.023_bib0060","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3109\/02656739409009351","article-title":"Arrhenius relationships from the molecule and cell to the clinic","volume":"10","author":"Dewey","year":"1994","journal-title":"Int. J. Hyperthermia."},{"issue":"8","key":"10.1016\/j.critrevonc.2019.04.023_bib0065","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1080\/02656730500271668","article-title":"Re-setting the biologic rationale for thermal therapy","volume":"21","author":"Dewhirst","year":"2005","journal-title":"Int. J. Hyperthermia."},{"issue":"2","key":"10.1016\/j.critrevonc.2019.04.023_bib0070","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10147-003-0369-x","article-title":"Whole-body hyperthermia in combination with platinum-containing drugs in patients with recurrent ovarian cancer","volume":"9","author":"Douwes","year":"2004","journal-title":"Int. J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2019.04.023_bib0075","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJMoa1708618","article-title":"Hyperthermic intraperitoneal chemotherapy in ovarian Cancer","volume":"378","author":"Driel","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2019.04.023_bib0080","first-page":"761","article-title":"Preliminary results in the treatment of oat cell carcinoma of the lung by combined application of chemotherapy (CT) and whole-body hyperthermia","volume":"107","author":"Engelhardt","year":"1982","journal-title":"Prog. Clin. Biol. Res."},{"issue":"3","key":"10.1016\/j.critrevonc.2019.04.023_bib0085","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3109\/02656739009140947","article-title":"Treatment of disseminated malignant melanoma with cisplatin in combination with whole-body hyperthermia and doxorubicin","volume":"6","author":"Engelhardt","year":"1990","journal-title":"Int. J. Hyperthermia."},{"issue":"1","key":"10.1016\/j.critrevonc.2019.04.023_bib0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/02656730150201552","article-title":"Hyperthermia in oncology","volume":"17","author":"Falk","year":"2001","journal-title":"Int. J. Hyperthermia."},{"issue":"6","key":"10.1016\/j.critrevonc.2019.04.023_bib0095","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3109\/02656736.2012.677933","article-title":"Old and new facts about hyperthermia-induced modulations of the immune system","volume":"28","author":"Frey","year":"2012","journal-title":"Int. J. Hyperthermia."},{"issue":"6","key":"10.1016\/j.critrevonc.2019.04.023_bib0100","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3109\/02656736.2012.677933","article-title":"Old and new facts about hyperthermia-induced modulations of the immune system","volume":"28","author":"Frey","year":"2012","journal-title":"Int. J. Hyperthermia."},{"issue":"4","key":"10.1016\/j.critrevonc.2019.04.023_bib0105","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.3892\/ol.2014.2376","article-title":"Sorafenib and locoregional deep electro-hyperthermia in advanced hepatocellular carcinoma: a phase II study","volume":"8","author":"Gadaleta-Caldarola","year":"2014","journal-title":"Oncol. Lett."},{"issue":"3","key":"10.1016\/j.critrevonc.2019.04.023_bib0110","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/BF00254197","article-title":"Renal failure and platinum pharmacokinetics in three patients treated with cis-diamminedichloroplatinum(II) and whole-body hyperthermia","volume":"11","author":"Gerad","year":"1983","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"12","key":"10.1016\/j.critrevonc.2019.04.023_bib0115","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1002\/1097-0142(19840615)53:12<2585::AID-CNCR2820531203>3.0.CO;2-2","article-title":"Doxorubicin, cyclophosphamide, and whole body hyperthermia for treatment of advanced soft tissue sarcoma","volume":"53","author":"Gerad","year":"1984","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.critrevonc.2019.04.023_bib0120","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/annonc\/mdf216","article-title":"Whole-body hyperthermia (41.8 C) combined with bimonthly oxaliplatin, high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer: a phase II study","volume":"13","author":"Hegewisch-Becker","year":"2002","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2019.04.023_bib0125","first-page":"259","article-title":"Whole-body hyperthermia and chemotherapy for treatment of patients with advanced, refractory malignancies","volume":"66","author":"Herman","year":"1982","journal-title":"Cancer Treat. Rep."},{"issue":"1","key":"10.1016\/j.critrevonc.2019.04.023_bib0130","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1040-8428(01)00179-2","article-title":"The cellular and molecular basis of hyperthermia","volume":"43","author":"Hildebrandt","year":"2002","journal-title":"Crit Rev Oncol Hematol."},{"issue":"3","key":"10.1016\/j.critrevonc.2019.04.023_bib0135","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/02656730310001637316","article-title":"Whole-body hyperthermia in the scope of von Ardenne\u2019s systemic cancer multistep therapy (sCMT) combined with chemotherapy in patients with metastatic colorectal cancer: a phase I\/II study","volume":"20","author":"Hildebrandt","year":"2004","journal-title":"Int. J. Hyperthermia."},{"issue":"2","key":"10.1016\/j.critrevonc.2019.04.023_bib0140","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/02656730400003401","article-title":"Current status of radiant whole-body hyperthermia at temperatures &41.5 degrees C and practical guidelines for the treatment of adults. The German\u2019 Interdisciplinary Working Group on Hyperthermia\u2019","volume":"21","author":"Hildebrandt","year":"2005","journal-title":"Int. J. Hyperthermia."},{"issue":"2","key":"10.1016\/j.critrevonc.2019.04.023_bib0145","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/jcpt.12498","article-title":"Chemoradiation combined with regional hyperthermia for advanced oesophageal cancer: a systematic review and meta-analysis","volume":"42","author":"Hu","year":"2017","journal-title":"J. Clin. Pharm. Ther."},{"issue":"6","key":"10.1016\/j.critrevonc.2019.04.023_bib0150","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1053\/j.seminoncol.2014.09.014","article-title":"Hyperthermia, radiation and chemotherapy: the role of heat in multidisciplinary cancer care","volume":"41","author":"Hurwitz","year":"2014","journal-title":"Semin. Oncol."},{"issue":"17","key":"10.1016\/j.critrevonc.2019.04.023_bib0155","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1016\/j.ejca.2008.07.038","article-title":"Hyperthermia adds to chemotherapy","volume":"44","author":"Issels","year":"2008","journal-title":"Eur. J. Cancer"},{"issue":"6","key":"10.1016\/j.critrevonc.2019.04.023_bib0160","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S1470-2045(10)70071-1","article-title":"Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study","volume":"11","author":"Issels","year":"2010","journal-title":"Lancet Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2019.04.023_bib0165","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1001\/jamaoncol.2017.4996","article-title":"Effect of neoadjuvant chemotherapy plus regional hyperthermia on long-term outcomes among patients with localized high-risk Soft tissue sarcoma: the EORTC 62961-ESHO 95 randomized clinical trial","volume":"4","author":"Issels","year":"2018","journal-title":"JAMA Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2019.04.023_bib0170","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1586\/erd.10.13","article-title":"Current devices for high-performance whole-body hyperthermia therapy","volume":"7","author":"Jia","year":"2010","journal-title":"Expert Rev. Med. Devices"},{"issue":"13","key":"10.1016\/j.critrevonc.2019.04.023_bib0175","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1158\/1078-0432.CCR-04-0133","article-title":"Thermochemoradiotherapy improves oxygenation in locally advanced breast cancer","volume":"10","author":"Jones","year":"2004","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.critrevonc.2019.04.023_bib0180","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/02656730500532028","article-title":"Cell biological effects of hyperthermia alone or combined with radiation or drugs: a short introduction to newcomers in the field","volume":"22","author":"Kampinga","year":"2006","journal-title":"Int. J. Hyperthermia."},{"issue":"2","key":"10.1016\/j.critrevonc.2019.04.023_bib0185","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S1359-6101(99)00006-4","article-title":"Whole body hyperthermia cytokine induction: a review, and unifying hypothesis for myeloprotection in the setting of cytotoxic therapy","volume":"10","author":"Katschinski","year":"1999","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.critrevonc.2019.04.023_bib0190","doi-asserted-by":"crossref","DOI":"10.1177\/1534735418794867","article-title":"Complete clinical remission of stage IV triple-negative breast Cancer lung metastasis administering low-dose immune checkpoint blockade in combination with hyperthermia and Interleukin-2","author":"Kleef","year":"2018","journal-title":"Integr. Cancer Ther."},{"issue":"24","key":"10.1016\/j.critrevonc.2019.04.023_bib0195","doi-asserted-by":"crossref","first-page":"9851","DOI":"10.1073\/pnas.1101053108","article-title":"Mild hyperthermia inhibits homologous recombination, induces BRCA2 degradation, and sensitizes cancer cells to poly (ADP-ribose) polymerase-1 inhibition","volume":"108","author":"Krawczyk","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"6 Pt 2","key":"10.1016\/j.critrevonc.2019.04.023_bib0200","first-page":"2252","article-title":"A clinical investigation of total-body hyperthermia as cancer therapy","volume":"39","author":"Larkin","year":"1979","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2019.04.023_bib0205","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13014-017-0813-0","article-title":"A short time interval between radiotherapy and hyperthermia reduces in-field recurrence and mortality in women with advanced cervical cancer","volume":"12","author":"Leeuwen","year":"2017","journal-title":"Radiat. Oncol."},{"issue":"11","key":"10.1016\/j.critrevonc.2019.04.023_bib0210","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.5301\/ijao.5000009","article-title":"Whole body hyperthermia by extracorporeal circulation in spontaneously breathing sarcoma patients: hemodynamics and oxygen metabolism","volume":"34","author":"Locker","year":"2011","journal-title":"Int. J. Artif. Organs"},{"key":"10.1016\/j.critrevonc.2019.04.023_bib0215","series-title":"Combined Use of Hyperthermia and Radiation Therapy for Treating Locally Advanced Cervix Carcinoma, Cochrane Database of Systematic Reviews","author":"Lutgens","year":"2010"},{"issue":"6","key":"10.1016\/j.critrevonc.2019.04.023_bib0220","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/1097-0142(19870315)59:6<1101::AID-CNCR2820590610>3.0.CO;2-G","article-title":"Clinical evaluation of total-body hyperthermia combined with anticancer chemotherapy for far-advanced miscellaneous cancer in Japan","volume":"59","author":"Maeta","year":"1987","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2019.04.023_bib0225","doi-asserted-by":"crossref","first-page":"10724","DOI":"10.1038\/s41598-018-29018-0","article-title":"Hyperthermia induces therapeutic effectiveness and potentiates adjuvant therapy with non-targeted and targeted drugs in an in vitro model of human malignant melanoma","volume":"8","author":"Mantso","year":"2018","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.critrevonc.2019.04.023_bib0230","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1634\/theoncologist.2014-0365","article-title":"Phase I study of cisplatin, hyperthermia, and lapatinib in patients with recurrent carcinoma of the uterine cervix in a previously irradiated area","volume":"20","author":"Meerten","year":"2015","journal-title":"Oncologist"},{"issue":"4","key":"10.1016\/j.critrevonc.2019.04.023_bib0235","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1080\/02656730902835664","article-title":"Combination of hyperthermia and bortezomib results in additive killing in mantle cell lymphoma cells","volume":"25","author":"Milani","year":"2009","journal-title":"Int. J. Hyperthermia."},{"issue":"3","key":"10.1016\/j.critrevonc.2019.04.023_bib0240","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1080\/02656730701772480","article-title":"The role of hyperthermia in optimizing tumor response to regional therapy","volume":"24","author":"Moyer","year":"2008","journal-title":"Int. J. Hyperthermia."},{"key":"10.1016\/j.critrevonc.2019.04.023_bib0245","series-title":"Moderate Whole-body Hyperthermia in Combination With Chemotherapy in the Treatment of Small Cell Carcinoma of the Lung: a Pilot Study","author":"Neumann","year":"1982"},{"key":"10.1016\/j.critrevonc.2019.04.023_bib0250","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s13014-015-0462-0","article-title":"Effects of hyperthermia on DNA repair pathways: one treatment to inhibit them all","volume":"10","author":"Oei","year":"2015","journal-title":"Radiat. Oncol."},{"issue":"10","key":"10.1016\/j.critrevonc.2019.04.023_bib0255","doi-asserted-by":"crossref","first-page":"16303","DOI":"10.18632\/oncotarget.11422","article-title":"Sensitizing thermochemotherapy with a PARP1-inhibitor","volume":"8","author":"Oei","year":"2017","journal-title":"Oncotarget"},{"issue":"3-4","key":"10.1016\/j.critrevonc.2019.04.023_bib0260","first-page":"323","article-title":"Physiologic response and toxicity in patients undergoing whole-body hyperthermia for the treatment of cancer","volume":"65","author":"Ostrow","year":"1981","journal-title":"Cancer Treat. Rep."},{"issue":"2","key":"10.1016\/j.critrevonc.2019.04.023_bib0265","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0167-8140(83)80019-X","article-title":"The importance of thermotolerance for the clinical treatment with hyperthermia","volume":"1","author":"Overgaard","year":"1983","journal-title":"Radiother Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2019.04.023_bib0270","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0022-5223(19)38032-8","article-title":"Treatment of far-advanced bronchogenic carcinoma by extracorporeally induced systemic hyperthermia","volume":"78","author":"Parks","year":"1979","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.critrevonc.2019.04.023_bib0275","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3389\/fonc.2017.00132","article-title":"Integrating Hyperthermia into Modern Radiation Oncology: What Evidence Is Necessary?","volume":"7","author":"Peeken","year":"2017","journal-title":"Front Oncol."},{"issue":"5946","key":"10.1016\/j.critrevonc.2019.04.023_bib0280","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1136\/bmj.4.5946.679","article-title":"Clinical effects of whole-body hyperthermia in adnanced malignancy","volume":"4","author":"Pettigrew","year":"1974","journal-title":"Br. Med. J."},{"issue":"4","key":"10.1016\/j.critrevonc.2019.04.023_bib0285","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/1759-7714.12346","article-title":"Pilot study of radiofrequency hyperthermia in combination with gefitinib in gefitinib-effective patients with advanced NSCLC","volume":"7","author":"Qin","year":"2016","journal-title":"Thoracic Cancer"},{"issue":"4","key":"10.1016\/j.critrevonc.2019.04.023_bib0290","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1158\/2326-6066.CIR-13-0118","article-title":"Temperature matters! And why it should matter to tumor immunologists","volume":"1","author":"Repasky","year":"2013","journal-title":"Cancer Immunol. Res."},{"issue":"3","key":"10.1016\/j.critrevonc.2019.04.023_bib0295","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.ygyno.2004.08.023","article-title":"Phase II study of carboplatin and whole body hyperthermia (WBH) in recurrent and metastatic cervical cancer","volume":"95","author":"Richel","year":"2004","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2019.04.023_bib0300","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.molcel.2010.10.006","article-title":"The heat shock response: life on the verge of death","volume":"40","author":"Richter","year":"2010","journal-title":"Molecular Cell"},{"issue":"9","key":"10.1016\/j.critrevonc.2019.04.023_bib0305","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1200\/JCO.1993.11.9.1787","article-title":"Phase I clinical trial of carboplatin and 41.8 degrees C whole-body hyperthermia in cancer patients","volume":"11","author":"Robins","year":"1993","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2019.04.023_bib0310","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0304-3835(95)03976-4","article-title":"Cytokine induction by 41.8 degrees C whole body hyperthermia","volume":"97","author":"Robins","year":"1995","journal-title":"Cancer letters"},{"issue":"1","key":"10.1016\/j.critrevonc.2019.04.023_bib0315","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1200\/JCO.1997.15.1.158","article-title":"Phase I clinical trial of melphalan and 41.8 degrees C whole-body hyperthermia in cancer patients","volume":"15","author":"Robins","year":"1997","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2019.04.023_bib0320","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s002800050915","article-title":"A pilot study of melphalan, tumor necrosis factor-alpha and 41.8 degrees C whole-body hyperthermia","volume":"43","author":"Robins","year":"1999","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"1","key":"10.1016\/j.critrevonc.2019.04.023_bib0325","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/02656730601091759","article-title":"Heat-induced alterations of nuclear protein associations and their effects on DNA repair and replication","volume":"23","author":"Roti Roti","year":"2007","journal-title":"Int. J. Hyperthermia."},{"issue":"1","key":"10.1016\/j.critrevonc.2019.04.023_bib0330","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/02656730701769841","article-title":"Cellular responses to hyperthermia (40-46 degrees C): cell killing and molecular events","volume":"24","author":"Roti Roti","year":"2008","journal-title":"Int. J. Hyperthermia."},{"key":"10.1016\/j.critrevonc.2019.04.023_bib0335","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jtherbio.2017.04.009","article-title":"Hyperthermia enhances bortezomib-induced apoptosis in human white blood cancer cells","volume":"67","author":"Saliev","year":"2017","journal-title":"J. Therm. Biol."},{"issue":"10","key":"10.1016\/j.critrevonc.2019.04.023_bib0340","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1158\/0008-5472.CAN-15-2908","article-title":"Hyperthermia synergizes with chemotherapy by inhibiting PARP1-Dependent DNA replication arrest","volume":"76","author":"Schaaf","year":"2016","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.critrevonc.2019.04.023_bib0345","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/02656730500204487","article-title":"Implications of increased tumor blood flow and oxygenation caused by mild temperature hyperthermia in tumor treatment","volume":"21","author":"Song","year":"2005","journal-title":"Int. J. Hyperthermia."},{"issue":"3","key":"10.1016\/j.critrevonc.2019.04.023_bib0350","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s12192-017-0843-4","article-title":"Heat shock proteins and DNA repair mechanisms: an updated overview","volume":"23","author":"Sottile","year":"2018","journal-title":"Cell Stress Chaperones"},{"issue":"3","key":"10.1016\/j.critrevonc.2019.04.023_bib0355","first-page":"556","article-title":"In vitro cytotoxic effect of tyrosine kinase inhibitor sunitinib malate alone and in combination with hyperthermia on breast adenocarcinoma MCF-7 cells","volume":"21","author":"Topcul","year":"2016","journal-title":"J. BUON"},{"issue":"8","key":"10.1016\/j.critrevonc.2019.04.023_bib0360","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3109\/02656736.2014.968640","article-title":"Local tumour hyperthermia as immunotherapy for metastatic cancer","volume":"30","author":"Toraya-Brown","year":"2014","journal-title":"Int. J. Hyperthermia."},{"issue":"4","key":"10.1016\/j.critrevonc.2019.04.023_bib0365","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/02656730210123534","article-title":"Thermal enhancement of melphalan and oxaliplatin cytotoxicity in vitro","volume":"18","author":"Urano","year":"2002","journal-title":"Int. J. Hyperthermia."},{"issue":"2","key":"10.1016\/j.critrevonc.2019.04.023_bib0370","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/026567399285765","article-title":"For the clinical application of thermochemotherapy given at mild temperatures","volume":"15","author":"Urano","year":"1999","journal-title":"Int. J. Hyperthermia."},{"issue":"9","key":"10.1016\/j.critrevonc.2019.04.023_bib0375","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0959-8049(01)00074-0","article-title":"A pilot study of whole body hyperthermia and carboplatin in platinum-resistant ovarian cancer","volume":"37","author":"Westermann","year":"2001","journal-title":"Eur. J. Cancer"},{"issue":"4","key":"10.1016\/j.critrevonc.2019.04.023_bib0380","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1159\/000070287","article-title":"A Systemic Hyperthermia Oncologic Working Group trial. Ifosfamide, carboplatin, and etoposide combined with 41.8 degrees C whole-body hyperthermia for metastatic soft tissue sarcoma","volume":"64","author":"Westermann","year":"2003","journal-title":"Oncology"},{"issue":"20","key":"10.1016\/j.critrevonc.2019.04.023_bib0385","first-page":"5346","article-title":"Ifosfamide and carboplatin combined with 41.8 degrees C whole-body hyperthermia in patients with refractory sarcoma and malignant teratoma","volume":"54","author":"Wiedemann","year":"1994","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.critrevonc.2019.04.023_bib0390","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/0959-8049(95)00622-2","article-title":"Ifosfamide, carboplatin and etoposide (ICE) combined with 41.8 degrees C whole body hyperthermia in patients with refractory sarcoma","volume":"32a","author":"Wiedemann","year":"1996","journal-title":"Eur. J. Cancer"},{"issue":"3","key":"10.1016\/j.critrevonc.2019.04.023_bib0395","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.tips.2016.11.009","article-title":"Heat shock proteins and Cancer","volume":"38","author":"Wu","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"issue":"8","key":"10.1016\/j.critrevonc.2019.04.023_bib0400","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S1470-2045(02)00818-5","article-title":"Hyperthermia in combined treatment of cancer","volume":"3","author":"Wust","year":"2002","journal-title":"Lancet Oncol."},{"issue":"8","key":"10.1016\/j.critrevonc.2019.04.023_bib0405","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1093\/annonc\/mdf280","article-title":"Heating the patient: a promising approach?","volume":"13","author":"Zee","year":"2002","journal-title":"Ann. Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2019.04.023_bib0410","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/j.athoracsur.2003.10.111","article-title":"Percutaneous venovenous perfusion-induced systemic hyperthermia for lung cancer: a phase I safety study","volume":"77","author":"Zwischenberger","year":"2004","journal-title":"Ann. Thorac. Surg."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842819300885?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842819300885?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T19:29:18Z","timestamp":1760902158000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842819300885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":82,"alternative-id":["S1040842819300885"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2019.04.023","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Whole-body hyperthermia in combination with systemic therapy in advanced solid malignancies","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2019.04.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}